Recent studies have determined a cholestatic variant of non-alcoholic fatty liver organ disease (NAFLD) with portal inflammation and ductular response. We show proof for posttranslational changes of FoxO3 including early (6 hours) deacetylation and dephosphorylation that coincide with localization of FoxO3 in the nuclear area. By 16 hours nuclear Sorafenib FoxO3 is both acetylated and… Continue reading Recent studies have determined a cholestatic variant of non-alcoholic fatty liver